Medtech Start-Ups Innovate In Urinary Incontinence
This article was originally published in Start Up
Executive Summary
Angel- and venture-backed medtech start-ups are working to fill the tremendous unmet need for alternative device options for treating (not just managing) female urinary incontinence a condition that has a significant impact on quality of life for millions of women. In this issue we profile Floelle, InControl Medical, NexHand, and Solace Therapeutics.
You may also be interested in...
Solace Therapeutics Inc.
Solace Therapeutics Inc.’s Solace Bladder Control System is a small, lightweight, polyurethane balloon device that fills with air once it is placed within the bladder, where it floats unobtrusively at the top of the organ, not blocking the urethra. The device is designed to eliminate or reduce involuntary urinary leakage by acting as a “shock absorber” to reduce the temporary peak pressure changes in the bladder that cause urinary leakage.
NexHand Inc.
NexHand Inc. has developed proprietary, sensor-based "smart surgical glove" technology designed to enable physicians to assess the severity of stress urinary incontinence. Its technology has been developed into two disposable products: the first is a noninvasive diagnostic tool for assessing the severity of SUI in the clinical setting, the UroGlove, and the second is a probe-based sensor for determining proper tensioning of urethral slings during surgery.
InControl Medical LLC
Transcutaneous electrical nerve stimulation technology has been used for decades to noninvasively treat acute and chronic pain in the muscles, joints, back, and neck. Now, InControl Medical LLC is employing it in the form of an intravaginal probe combined with patient biofeedback and quantitative physician feedback to treat one of the largest and fastest growing female health care problems, stress and mixed urinary incontinence.